Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

F. Briand · SciRah

Researcher profile · Semantic Scholar

F. Briand

Share profile

F. Briand — researcher profile on SciRah

h-index: 22
Works: 90
Citations: 1,687

Most-cited papers

Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity
Jin Li, T. Casteels, T. Frogne, C. Ingvorsen +36 more
2017Cell338 citations Open access
Semantic Scholar
Empagliflozin, via Switching Metabolism Toward Lipid Utilization, Moderately Increases LDL Cholesterol Levels Through Reduced LDL Catabolism
F. Briand, E. Mayoux, E. Brousseau, Noémie Burr +4 more
2016Diabetes115 citations
Semantic Scholar
P2Y13 receptor is critical for reverse cholesterol transport
Aurélie Fabre, C. Malaval, Abduelhakem Ben Addi, Céline Verdier +13 more
2010Hepatology103 citations Open access
Semantic Scholar
Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters
V. Sencio, Arnaud Machelart, C. Robil, N. Benech +20 more
2021Gut microbes83 citations Open access
Semantic Scholar
Anacetrapib promotes reverse cholesterol transport and bulk cholesterol excretion in Syrian golden hamsters
J. Castro-Pérez, F. Briand, K. Gagen, Sheng-Ping Wang +9 more
2011Journal of Lipid Research80 citations Open access
Semantic Scholar
Both the Peroxisome Proliferator-Activated Receptor (PPAR) delta agonist, GW0742, and ezetimibe promote reverse cholesterol transport in mice by reducing intestinal re-absorption of HDL-derived cholesterol
F. Briand, S. Naik, I. Fuki, John S. Millar +5 more
2009Clinical and Translational Science76 citations Open access
Semantic Scholar
Biliary sterol secretion is required for functional in vivo reverse cholesterol transport in mice.
N. Nijstad, T. Gautier, F. Briand, D. Rader +1 more
2011Gastroenterology68 citations Open access
Semantic Scholar
Modulation of HDL Metabolism by the Niacin Receptor GPR109A in Mouse Hepatocytes
Xiao-Yu Li, J. Millar, N. Brownell, F. Briand +1 more
2010Biochemical Pharmacology58 citations Open access
Semantic Scholar
Probiotic B420 and prebiotic polydextrose improve efficacy of antidiabetic drugs in mice
L. Stenman, A. Waget, C. Garret, F. Briand +3 more
2015Diabetology & Metabolic Syndrome55 citations Open access
Semantic Scholar
High-fat and fructose intake induces insulin resistance, dyslipidemia, and liver steatosis and alters in vivo macrophage-to-feces reverse cholesterol transport in hamsters.
F. Briand, Q. Thiéblemont, E. Muzotte, T. Sulpice
2012Journal of NutriLife43 citations Open access
Semantic Scholar
Obeticholic acid raises LDL‐cholesterol and reduces HDL‐cholesterol in the Diet‐Induced NASH (DIN) hamster model
F. Briand, E. Brousseau, Marjolaine Quinsat, R. Burcelin +1 more
2018European Journal of Pharmacology42 citations
Semantic Scholar
Liraglutide targets the gut microbiota and the intestinal immune system to regulate insulin secretion
J. Charpentier, F. Briand, B. Lelouvier, F. Servant +13 more
2021Acta Diabetologica38 citations
Semantic Scholar
Nephropathy in diabetic db/db mice is accelerated by high protein diet and improved by the SGLT2 inhibitor dapagliflozin.
Sisse A Nørgaard, F. Briand, F. W. Sand, E. Galsgaard +3 more
2019European Journal of Pharmacology38 citations
Semantic Scholar
Abstract 1101: Liver X Receptor Activation Promotes Macrophage-to-Feces Reverse Cholesterol Transport in a Dyslipidemic Hamster Model
F. Briand, Morgan Tréguier, A. André, D. Grillot +3 more
200936 citations
Semantic Scholar
The use of dyslipidemic hamsters to evaluate drug-induced alterations in reverse cholesterol transport.
F. Briand
2010Current opinion in investigational drugs33 citations
Semantic Scholar
Elafibranor improves diet-induced nonalcoholic steatohepatitis associated with heart failure with preserved ejection fraction in Golden Syrian hamsters.
F. Briand, J. Maupoint, E. Brousseau, N. Breyner +10 more
2021Metabolism: Clinical and Experimental32 citations Open access
Semantic Scholar
Diet‐induced dyslipidemia impairs reverse cholesterol transport in hamsters
Morgan Tréguier, F. Briand, A. Boubacar, A. André +5 more
2011European Journal of Clinical Investigation31 citations
Semantic Scholar
Molecular imaging of liver inflammation using an anti-VCAM-1 nanobody
M. Nachit, C. Montemagno, Romain Clerc, M. Ahmadi +9 more
2023Nature Communications25 citations Open access
Semantic Scholar
Upregulating Reverse Cholesterol Transport With Cholesteryl Ester Transfer Protein Inhibition Requires Combination With the LDL-Lowering Drug Berberine in Dyslipidemic Hamsters
F. Briand, Q. Thiéblemont, E. Muzotte, T. Sulpice
2013Arteriosclerosis, Thrombosis and Vascular Biology25 citations
Semantic Scholar
A 3‐week nonalcoholic steatohepatitis mouse model shows elafibranor benefits on hepatic inflammation and cell death
F. Briand, C. Heymes, Lucile Bonada, Thibault Angles +7 more
2020Clinical and Translational Science24 citations Open access
Semantic Scholar
Saccharomyces boulardii CNCM I-745 changes lipidemic profile and gut microbiota in a hamster hypercholesterolemic model.
F. Briand, T. Sulpice, P. Giammarinaro, X. Roux
2019Beneficial Microbes23 citations Open access
Semantic Scholar
Liraglutide improves hepatic steatosis and metabolic dysfunctions in a 3-week dietary mouse model of non-alcoholic steatohepatitis
T. Duparc, F. Briand, C. Trenteseaux, J. Mérian +4 more
2019bioRxiv23 citations Open access
Semantic Scholar
Metabolism of cholesterol ester of apolipoprotein B100‐containing lipoproteins in dogs: evidence for disregarding cholesterol ester transfer
E. Bailhache, F. Briand, P. Nguyen, M. Krempf +2 more
2004European Journal of Clinical Investigation22 citations
Semantic Scholar
Alteration of the gut microbiota’s composition and metabolic output correlates with COVID-19-like severity in obese NASH hamsters
V. Sencio, N. Benech, C. Robil, L. Deruyter +8 more
2022Gut microbes20 citations Open access
Semantic Scholar
The hepatic compensatory response to elevated systemic sulfide promotes diabetes
Roderick N. Carter, M. Gibbins, M. Barrios-Llerena, Stephen E. Wilkie +25 more
2020bioRxiv20 citations Open access
Semantic Scholar
Sitagliptin promotes macrophage‐to‐faeces reverse cholesterol transport through reduced intestinal cholesterol absorption in obese insulin resistant CETP‐apoB100 transgenic mice
F. Briand, Quentin Thieblemont, R. Burcelin, T. Sulpice
2012Diabetes, obesity and metabolism20 citations
Semantic Scholar
CETP Inhibitor Torcetrapib Promotes Reverse Cholesterol Transport in Obese Insulin‐Resistant CETP‐ApoB100 Transgenic Mice
F. Briand, Q. Thiéblemont, A. André, K. Ouguerram +1 more
2011Clinical and Translational Science20 citations Open access
Semantic Scholar
Evaluation of Antiatherogenic Properties of Ezetimibe Using 3H-Labeled Low-Density-Lipoprotein Cholesterol and 99mTc-cAbVCAM1–5 SPECT in ApoE−/− Mice Fed the Paigen Diet
Laurent S. Dumas, F. Briand, Romain Clerc, E. Brousseau +13 more
2017Journal of Nuclear Medicine17 citations Open access
Semantic Scholar
Fenofibrate lowers lipid parameters in obese dogs.
S. Serisier, F. Briand, K. Ouguerram, B. Siliart +2 more
2006Journal of NutriLife17 citations Open access
Semantic Scholar
Selective uptake of high density lipoproteins cholesteryl ester in the dog, a species lacking in cholesteryl ester transfer protein activity; An in vivo approach using stable isotopes.
K. Ouguerram, P. Nguyen, M. Krempf, E. Pouteau +3 more
2004Comparative Biochemistry and Physiology Part B Comparative Biochemistry17 citations
Semantic Scholar
Raising HDL with CETP inhibitor torcetrapib improves glucose homeostasis in dyslipidemic and insulin resistant hamsters.
F. Briand, Bénédicte Prunet-Marcassus, Q. Thiéblemont, C. Costard +3 more
2014Atherosclerosis16 citations
Semantic Scholar
Low molecular weight heparin self-injection training: assessment of feasibility, tolerance and economic analysis in emergency departments
C. le Gall, E. Jacques, Claude Medjebeur, Loic Darques +3 more
2006European journal of emergency medicine15 citations
Semantic Scholar
Improvement of NASH and liver fibrosis through modulation of the gut-liver axis by a novel intestinal FXR agonist.
An-Na Moon, F. Briand, Natalia Breyner, D. Song +5 more
2024Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie14 citations Open access
Semantic Scholar
Anacetrapib and dalcetrapib differentially alters HDL metabolism and macrophage-to-feces reverse cholesterol transport at similar levels of CETP inhibition in hamsters.
F. Briand, Q. Thiéblemont, E. Muzotte, Noémie Burr +3 more
2014European Journal of Pharmacology13 citations
Semantic Scholar
Diet-Induced Obesity and NASH Impair Disease Recovery in SARS-CoV-2-Infected Golden Hamsters
F. Briand, V. Sencio, C. Robil, S. Heumel +15 more
2022Viruses12 citations Open access
Semantic Scholar
Effects of atorvastatin on high‐density lipoprotein apolipoprotein A‐I metabolism in dogs
F. Briand, T. Magot, M. Krempf, Patrick Nguyen +1 more
2006European Journal of Clinical Investigation10 citations
Semantic Scholar
The hyperenergetic-fed obese dog, a model of disturbance of apolipoprotein B-100 metabolism associated with insulin resistance: kinetic study using stable isotopes.
F. Briand, E. Bailhache, A. André, T. Magot +3 more
2008Metabolism: Clinical and Experimental8 citations
Semantic Scholar
Atorvastatin increases intestinal cholesterol absorption in dogs.
F. Briand, S. Serisier, M. Krempf, B. Siliart +3 more
2006Journal of NutriLife6 citations Open access
Semantic Scholar
Résistance du carpocapse Cydia pomonella aux insecticides : Tests par application topique sur des larves diapausantes collectées en automne 2003 dans les vergers suisses
P. Charmillot, D. Pasquier, F. Briand
20056 citations
Semantic Scholar
CX3CR1 regulates gut microbiota and metabolism. A risk factor of type 2 diabetes
Céline Pomié, F. Servant, L. Garidou, V. Azalbert +9 more
2021Acta Diabetologica5 citations
Semantic Scholar
Metabolism of high density lipoprotein apolipoprotein A‐I and cholesteryl ester in insulin resistant dog: a stable isotope study
F. Briand, E. Bailhache, P. Nguyen, M. Krempf +2 more
2007Diabetes, obesity and metabolism5 citations
Semantic Scholar
Effects of atorvastatin on high‐density lipoprotein apolipoprotein A‐I metabolism in dogs
F. Briand, T. Magot, M. Krempf, P. Nguyen +1 more
20065 citations
Semantic Scholar
Ezetimibe Enhances Macrophage-to-Feces Reverse Cholesterol Transport in Golden Syrian Hamsters Fed a High-Cholesterol Diet
Fatima Kasbi-Chadli, Morgan Tréguier, F. Briand, T. Sulpice +1 more
2020Journal of Pharmacology and Experimental Therapeutics4 citations Open access
Semantic Scholar
Liraglutide shows superior cardiometabolic benefits than lorcaserin in a novel free choice diet-induced obese rat model.
F. Briand, E. Brousseau, J. Maupoint, C. Dubroca +4 more
2020European Journal of Pharmacology4 citations
Semantic Scholar
Small Cages with Insect Couples Provide a Simple Method for a Preliminary Assessment of Mating Disruption
F. Briand, P. Guerin, P. Charmillot, P. Kehrli
2012TheScientificWorldJournal4 citations Open access
Semantic Scholar
Effects of excessive sodium chloride loading in the spontaneously diabetic torii (SDT) fatty rats, a preclinical model of type 2 diabetes mellitus.
Soon Hui Teoh, K. Miyajima, Y. Shinozaki, M. Shinohara +9 more
2021Journal of Toxicological Sciences3 citations Open access
Semantic Scholar
Abstract 823: Inhibition of Cholesterol Absorption with Ezetimibe Promotes Macrophage to Feces Reverse Cholesterol Transport in Mice
F. Briand, J. Millar, J. Billheimer, G. Rothblat +1 more
20073 citations
Semantic Scholar
New pheromone-based methods for grape moth control. Preliminary trials in 2004
P. Charmillot, T. Degen, D. Pasquier, F. Briand
20053 citations
Semantic Scholar
272-OR: Weight Loss with Time-Restricted Feeding or Treatment with Obeticholic Acid/Semaglutide Combination Have a Different Impact on Nonalcoholic Steatohepatitis in Diet-Induced Obese Mice
F. Briand, E. Grasset, N. Breyner, T. Sulpice
2022Diabetes2 citations
Semantic Scholar
EDP-305, a novel and highly potent farnesoid X receptor agonist, improves liver steatosis, ballooning and non-alcoholic fatty liver disease (NAFLD) activity score (NAS) in a diet-induced murine model of non-alcoholic steatohepatitis
L.-J. Jiang, M. Chau, Y. Li, F. Briand +2 more
20172 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

T. Sulpice×30
Invite
T. Sulpice — researcher profile on SciRah
K. Ouguerram×12
Invite
K. Ouguerram — researcher profile on SciRah
T. Magot×9
Invite
T. Magot — researcher profile on SciRah
R. Burcelin×8
Invite
R. Burcelin — researcher profile on SciRah

×8

Invite

P. Nguyen — researcher profile on SciRah

E. Brousseau×7

Invite

E. Brousseau — researcher profile on SciRah

Invite

M. Krempf — researcher profile on SciRah

Q. Thiéblemont×5

Invite

Q. Thiéblemont — researcher profile on SciRah

Invite

C. Costard — researcher profile on SciRah

Invite

E. Muzotte — researcher profile on SciRah

Invite

A. André — researcher profile on SciRah

Invite

V. Sencio — researcher profile on SciRah